Home
Conditions
Stage IV Melanoma

Clinical trial condition

Stage IV Melanoma

Explore clinical trials studying Stage IV Melanoma. Study availability and eligibility vary by location and protocol.

69 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage IV Melanoma trial results

Completed

An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma

NCT01136967

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Birmingham, Alabama, United States

Tucson, Arizona, United States

Los Angeles, California, United States

San Francisco, California, United States

View all 95 locations

View Trial Details

Completed

Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma

NCT01107665

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: Chao Family Comprehensive Cancer Center Orange, California, United States

View Trial Details

Completed

A Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients (PSX-X03)

NCT00438009

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Princess Alexandra Hospital Brisbane, Queensland, Australia

View Trial Details

Completed

Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma

NCT02306850

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +13 more
Locations: Saint Louis University Hospital St Louis, Missouri, United States

View Trial Details

Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

NCT00121225

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Eye Diseases, +20 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Fox Chase Cancer Center Rockledge, Pennsylvania, United States

Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma

NCT01010984

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: University of Louisville Louisville, Kentucky, United States

Thomas Jefferson University Philadelphia, Pennsylvania, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery

NCT01748747

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +17 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

NCT00243061

Conditions: Acral Lentiginous Malignant Melanoma, Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, +25 more
Locations: Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

NCT02166255

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +40 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers

NCT00074308

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +13 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Stage IV Melanoma

Stage IV Melanoma trial results

Related conditions